Anavex Life Sciences Corp (AVXL)

[powerwalker]

New Alzheimer’s drug raises hopes — along with questions

FYI from Endpoints

Notable paragraph

In a briefing document, Eisai, the company that makes Leqembi, said clinical trials showed a 27% slower rate of decline for people taking the drug. But when raw scores on the cognitive scale used to measure results are considered (4.41 for the Leqembi group at the end of 18 months versus 4.86 for the placebo group), the rate of improvement was 9%, according to Lon Schneider, a professor of psychiatry, neurology, and gerontology at the University of Southern California’s Keck School of Medicine.

https://endpts.com/new-alzheimers-drug-raises-hopes-along-with-questions/